Bernsmeier et al. showed that the secretion of GLP-1 in patients with NAFLD was significantly lower than that in normal subjects, suggesting that GLP-1 secretion is impaired in patients with NAFLD [55]. This evidence concerns the gene GLP1R and metabolic dysfunction-associated steatotic liver disease.